SO

Healthcare · Pharmaceuticals

Solara Active Pharma Sciences Ltd (SOLARA)

₹628.25

Mkt cap
₹3,050 Cr
P/E ratio
64.40
P/B
2.12
Div yield
0.00%
ROE
−0.13%
ROCE
4.86%
EPS (TTM)
₹9.76
Book value
₹296
52W range
422–774
Sector
Healthcare

Price history

Previous close

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs. [1] It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same time, making it a pure play API company. [2]

NSE SOLARABSE 541540
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−18.83% from high
₹628
₹422+48.87% from low₹774
Current
₹628.25
Prev close
₹640.60
Day
−1.93%
Price performance
1D
−1.45%
1W
−8.46%
1M
+1.98%
3M
−1.36%
6M
+11.88%
1Y
+10.18%
YTD
+7.94%

Financials

Revenue, profit & margin
P/E ratio
64.4×
SOLARA is 98% above the sector median of 32.5×
SOLARA64.4×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales425212299363347300273319314349387382417
YoY Sales growth+26%-46%-21%+3%-18%+42%-9%-12%-10%+16%+42%+20%+33%
Expenses388374290322286243228262279312330320340
Operating Profit38-1621042615845573537586277
OPM %9%-76%3.3%12%18%19%17%18%11%11%15%16%18%
Other Income-4-62-120101610-763-4
Interest24253131282729242122282218
Depreciation26262525252524242426262727
Profit before tax-17-275-167-1388-211-10-17101628
Tax %0%0%53%0%0%0%0%0%0%0%0%0%0%
Net Profit-17-275-255-1388-211-10-17101628
EPS in Rs-4.39-70.42-65.30-3.742.222.24-0.582.91-2.79-4.822.653.385.86
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −7.33% · closed higher next day 0 of last 1
 Q2FY27
Broadcast16 Oct '26◦
Earnings day−7.33%
+1 day−6.95%
+5 days−8.61%
+15 days−4.05%
+30 days—
FilingXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
41.93%Promoter
Promoters41.93%
FIIs10.71%0.81
DIIs3.89%0.15
Public43.46%0.67
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.764,52,2510.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.161,78,3740.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.531,23,9800.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.421,19,7000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.471,16,1190.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.811,14,3160.92%852−35.05%7,404−2.44%15.49%
Solara Active₹628.2564.433,0500.00%28+426.34%417+33.11%4.86%
Median: 160 Co.₹432.2032.471,9830.08%13+33.73%179+21.23%14.94%

Filings